Skip to search formSkip to main contentSkip to account menu

tiplaxtinin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Preoperative chemotherapy is a promising strategy for the treatment of esophageal squamous cell carcinoma (ESCC). Acquired… 
Highly Cited
2013
Highly Cited
2013
Cancers of the urinary bladder result in aggressive and highly angiogenic tumors for which standard treatments have only limited… 
2012
2012
Spatial and temporal regulation of the pericellular proteolytic environment by local growth factors, such as EGF and TGF… 
2008
2008
Summary.  Objective: To assess the antithrombotic and profibrinolytic effects of tiplaxtinin (PAI‐039), an orally bioavailable… 
2008
2008
This study aimed to evaluate a small-molecule PAI-1 inhibitor (PAI-039; tiplaxtinin) in a rodent stenosis model of venous… 
2006
2006
To investigate the effect of tiplaxtinin, designed as a synthetic inhibitor of plasminogen activator inhibitor-1 (PAI-1), on… 
Highly Cited
2006
Highly Cited
2006
Hepatic veno-occlusive disease (VOD) is a common complication of high-dose chemotherapy associated with bone marrow… 
Highly Cited
2004
Highly Cited
2004
Indole oxoacetic acid derivatives were prepared and evaluated for in vitro binding to and inactivation of human plasminogen…